The global eClinical solutions market was valued at USD 10.28 billion in 2024 and is expected to reach USD 22.74 billion by 2030, advancing at a CAGR of 14.39% from 2025 to 2030. The continuous rise in research and development activities undertaken by pharmaceutical and biopharmaceutical companies remains a significant factor driving market expansion. Increasing adoption of digital platforms and the integration of advanced software tools across clinical trial processes further supports industry growth.

Key Market Trends & Insights

• North America dominated the global eClinical solutions industry, accounting for the largest revenue share of 48.88% in 2024.
• The U.S. held the largest share within the region in 2024.
• By product, the CTMS segment led the market, contributing 20.27% of revenue in 2024.
• Based on delivery mode, the web- and cloud-based segment dominated the market throughout 2024.
• Among end users, CROs accounted for the largest revenue share in 2024.
• By development phase, the Phase III segment held the dominant share in 2024.

Market Size & Forecast

• 2024 Market Size: USD 10.28 Billion
• 2030 Projected Market Size: USD 22.74 Billion
• CAGR (2025–2030): 14.39%
• Largest Regional Market (2024): North America

The rising incorporation of software platforms in clinical trial workflows continues to enhance operational efficiency and data management, providing strong stimulus to the market. The growing outsourcing and externalization of clinical trials by major pharmaceutical and biotechnology companies is projected to significantly accelerate market growth in the coming years.

Stringent regulatory frameworks for clinical trials, coupled with the heightened need for safety monitoring, especially in developed markets like the U.S., are strengthening the adoption of eClinical tools. Regulatory bodies such as the U.S. Department of Health and Human Services and the National Institutes of Health are intensifying clinical trial registration requirements and promoting improved data transparency and sharing.

The market further benefited during the COVID-19 pandemic, as organizations invested heavily in advanced healthcare IT solutions. For example, in April 2020, eClinical Solutions LLC launched elluminate COVID-19 analytics, enabling sponsors to effectively manage pandemic-related disruptions in ongoing trials.

Order a free sample PDF of the eClinical Solutions Market Intelligence Study, published by Grand View Research.

Key eClinical Solutions Companies Insights

Leading companies in the market continue to emphasize geographic expansion, strategic partnerships, and innovative product development to widen their market reach. Collaborative initiatives remain central to strengthening competitive positioning.

Key eClinical Solutions Companies

• Datatrak International, Inc.
• Oracle
• Parexel International Corporation
• Dassault Systèmes
• Bioclinica
• CRF Health
• ERT Clinical
• eClinicalWorks
• Merative (formerly IBM Watson Health; acquired by Francisco Partners in June 2022)
• Anju Life Sciences Software
• eClinical Solutions
• Maxisit
• IQVIA
• Castor
• Veeva Systems
• RealTime Software Solutions, LLC
• Medidata Solution, Inc.
• ICON, plc
• Prominent AI-Powered eClinical Solution Providers
• Deep 6 AI (acquired by Tempus on March 12, 2025)
• Phesi
• Curebase
• Saama
• Suvoda LLC (merged with Greenphire in April 2025)
• Cencora Pharmalex (acquired by AmerisourceBergen Corporation in January 2023)
• Clinion
• Jeeva Clinical Trials Inc.
• Trial Interactive by TransPerfect

Conclusion

The eClinical solutions market is positioned for substantial growth as pharmaceutical and biopharmaceutical industries rapidly transition toward digitalized and data-driven clinical trial ecosystems. Enhanced regulatory oversight, rising trial complexity, increasing reliance on CROs, and accelerated adoption of advanced platforms such as AI-driven analytics continue to strengthen demand. Expanding R&D activities, broader adoption of cloud-based tools, and the emergence of cost-effective digital modules in developing regions further enhance the sector’s long-term potential.

Explore Horizon Databook – The world’s most expansive market intelligence platform developed by Grand View Research.